バレニクリンの世界市場レポート 2024年

バレニクリン市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.3％で21億7,000万米ドルに成長します。予測期間中の成長予測は、禁煙研究の進展、新興市場への進出、デジタルヘルスソリューションとの統合、政府支援や補助金、個別化医療への注目の高まりなどに起因しています。予測期間における主な動向には、デジタルヘルス技術との統合、併用療法の開発、個別化禁煙プラン、政府の拡大、保険適用などがあります。

喫煙中毒の有病率の増加は、今後のバレニクリン市場の成長を促進すると予測されます。タバコやその他のタバコ製品へのアクセスが容易であること、特に個人の間で社会的影響や同調圧力があることなどの要因が、喫煙率の上昇に寄与しています。バレニクリンは処方薬で、ニコチンの快楽作用を弱めながら、禁煙欲求や禁断症状を軽減し、禁煙を支援するように設計されています。例えば、2022年7月、カナダの政府機関であるカナダ統計局は、2021年6月と比較してタバコの生産量が5.8％増加したと報告しました。さらに、タバコの総販売本数は2022年5月から1.3％増加し、2022年6月には14億本に達しました。その結果、喫煙中毒の有病率の増加がバレニクリン市場を押し上げると予想されます。

バレニクリン市場の主要企業は、さまざまな地域での市場リーダーシップを強化し、競争優位性を確保するために、ジェネリック錠剤などの新しい製剤や市場開発方法の開発に注力しています。バレニクリンのジェネリック錠剤は、バレニクリン酒石酸塩を含む医薬品の非ブランド品で、先発品と生物学的に同等であり、禁煙治療に使用されます。例えば、2024年1月、インドを拠点とする製薬会社Lupin Limitedは、米国で0.5mgと1mgの強さの新しいバレニクリン錠剤を発売しました。これらの錠剤は、P.F. Prism C.V.社のChantix錠剤（0.5mgおよび1mg）のジェネリック医薬品で、禁煙治療をサポートすることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のバレニクリン市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のバレニクリン市場の実績：規模と成長, 2018-2023
• 世界のバレニクリン市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界のバレニクリン市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• マグネシウム錠
• 1mg錠
• 世界のバレニクリン市場：投与経路別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 経口
• 舌下投与
• 経皮
• 世界のバレニクリン市場：患者タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 喫煙者
• 元喫煙者
• 辞める前
• 世界のバレニクリン市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院
• ドラッグストア

第7章 地域別・国別分析

• 世界のバレニクリン市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のバレニクリン市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バレニクリン市場：競合情勢
• バレニクリン市場：企業プロファイル
  • Pfizer Inc.
  • Biocon Limited
  • Oyster Point Pharma Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.

第31章 その他の大手企業と革新的企業

• Sandoz International GmbH
• Nanjing Clasien Pharmaceutical & Chemical Co. Ltd.
• Hetero Drugs Limited
• Sun Pharmaceutical Industries Ltd
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Apotex Inc
• Amneal Pharmaceuticals LLC
• Lupin Limited
• Alkem Laboratories Ltd
• Glenmark Pharmaceuticals Limited
• Jubilant Life Sciences Limited
• Alembic Pharmaceuticals Limited
• Torrent Pharmaceuticals Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Varenicline is a medication designed to assist with smoking cessation by alleviating withdrawal symptoms and blocking the effects of nicotine on the brain. It functions as a partial agonist at nicotinic acetylcholine receptors, helping to reduce cravings and making the process of quitting smoking more manageable.

The primary forms of varenicline are 0.5 mg tablets and 1 mg tablets. The 0.5 mg tablets are used to gradually decrease nicotine cravings and withdrawal symptoms, aiding users in the process of quitting smoking and enhancing long-term success. Varenicline can be administered orally, sublingually, or transdermally, and is intended for use by smokers, ex-smokers, and those preparing to quit. Its applications include hospitals and drug stores.

The varenicline market research report is one of a series of new reports from the business research company that provides varenicline market statistics, including varenicline industry global market size, regional shares, competitors with an varenicline market share, detailed varenicline market segments, market trends and opportunities, and any further data you may need to thrive in the varenicline industry. This varenicline market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The varenicline market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The increase observed during the historic period can be attributed to the rise in smoking cessation initiatives, regulatory approvals and recommendations, effective and safe profiles, heightened research and development efforts, and the growing incidence of smoking-related diseases.

The varenicline market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The projected growth during the forecast period can be attributed to advancements in smoking cessation research, expansion into emerging markets, integration with digital health solutions, government support and subsidies, and a heightened focus on personalized medicine. Key trends in the forecast period include the integration with digital health technologies, the development of combination therapies, personalized smoking cessation plans, government expansion, and insurance coverage.

The increasing prevalence of smoking addiction is projected to drive the growth of the varenicline market in the future. Factors such as easy access to cigarettes and other tobacco products, along with social influences and peer pressure, particularly among individuals, are contributing to higher smoking rates. Varenicline is a prescription medication designed to aid smoking cessation by reducing cravings and withdrawal symptoms while also diminishing the pleasurable effects of nicotine. For example, in July 2022, Statistics Canada, a Canadian government agency, reported a 5.8% increase in cigarette production compared to June 2021. Additionally, the total number of cigarettes sold rose by 1.3% from May 2022, reaching 1.4 billion in June 2022. Consequently, the growing prevalence of smoking addiction is expected to boost the varenicline market.

Major players in the varenicline market are concentrating on developing new formulations and delivery methods, such as generic tablets, to enhance their market leadership across various regions and secure a competitive advantage. Generic varenicline tablets are non-branded versions of the medication containing varenicline tartrate, which is bioequivalent to the original branded product and is used for smoking cessation therapy. For example, in January 2024, Lupin Limited, an India-based pharmaceutical company, introduced new varenicline tablets in the United States, available in 0.5 mg and 1 mg strengths. These tablets are generic versions of Chantix tablets (0.5 mg and 1 mg) from P.F. Prism C.V. and are intended to support smoking cessation treatment.

In April 2023, SK Capital Partners LP, a US-based private investment firm, acquired Apotex Pharmaceutical Holdings Inc. for an undisclosed amount. Through this acquisition, SK Capital aims to utilize Apotex's renowned brand, extensive product portfolio, global reach, and experienced team to drive growth and boost shareholder value. Apotex Pharmaceutical Holdings Inc., a Canadian pharmaceutical company, produces drugs for smoking addiction, including varenicline.

Major companies operating in the varenicline market are Pfizer Inc., Biocon Limited, Oyster Point Pharma Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Nanjing Clasien Pharmaceutical & Chemical Co. Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Apotex Inc, Amneal Pharmaceuticals LLC, Lupin Limited, Alkem Laboratories Ltd, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Medley Pharmaceuticals Ltd, Wockhardt Ltd, Par Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Cadila Healthcare Limited (Zydus Cadila), Lee Pharma Limited, Viwit Pharmaceuticals Limited, Leading Pharma LLC

North America was the largest region in the varenicline market in 2023. The regions covered in the varenicline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the varenicline market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The varenicline market consists of sales of par pharmaceutical varenicline, champix, and injections, as well as extended-release or combination therapies used for smoking cessation. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Varenicline Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on varenicline market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for varenicline ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The varenicline market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 0.5 Mg Tablets; 1 Mg Tablets
• 2) By Route Of Administration: Oral; Sublingual; Transdermal
• 3) By Patient Type: Smokers; Ex Smokers; Pre Quitters
• 4) By Application: Hospital; Drug Store
• Companies Mentioned: Pfizer Inc.; Biocon Limited; Oyster Point Pharma Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Varenicline Market Characteristics

3. Varenicline Market Trends And Strategies

4. Varenicline Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Varenicline Market Size and Growth

• 5.1. Global Varenicline Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Varenicline Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Varenicline Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Varenicline Market Segmentation

• 6.1. Global Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 0.5 Mg Tablets
• 1 Mg Tablets
• 6.2. Global Varenicline Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Sublingual
• Transdermal
• 6.3. Global Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Smokers
• Ex Smokers
• Pre Quitters
• 6.4. Global Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Drug Store

7. Varenicline Market Regional And Country Analysis

• 7.1. Global Varenicline Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Varenicline Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Varenicline Market

• 8.1. Asia-Pacific Varenicline Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Varenicline Market

• 9.1. China Varenicline Market Overview
• 9.2. China Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Varenicline Market

• 10.1. India Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Varenicline Market

• 11.1. Japan Varenicline Market Overview
• 11.2. Japan Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Varenicline Market

• 12.1. Australia Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Varenicline Market

• 13.1. Indonesia Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Varenicline Market

• 14.1. South Korea Varenicline Market Overview
• 14.2. South Korea Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Varenicline Market

• 15.1. Western Europe Varenicline Market Overview
• 15.2. Western Europe Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Varenicline Market

• 16.1. UK Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Varenicline Market

• 17.1. Germany Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Varenicline Market

• 18.1. France Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Varenicline Market

• 19.1. Italy Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Varenicline Market

• 20.1. Spain Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Varenicline Market

• 21.1. Eastern Europe Varenicline Market Overview
• 21.2. Eastern Europe Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Varenicline Market

• 22.1. Russia Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Varenicline Market

• 23.1. North America Varenicline Market Overview
• 23.2. North America Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Varenicline Market

• 24.1. USA Varenicline Market Overview
• 24.2. USA Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Varenicline Market

• 25.1. Canada Varenicline Market Overview
• 25.2. Canada Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Varenicline Market

• 26.1. South America Varenicline Market Overview
• 26.2. South America Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Varenicline Market

• 27.1. Brazil Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Varenicline Market

• 28.1. Middle East Varenicline Market Overview
• 28.2. Middle East Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Varenicline Market

• 29.1. Africa Varenicline Market Overview
• 29.2. Africa Varenicline Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Varenicline Market, Segmentation By Patient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Varenicline Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Varenicline Market Competitive Landscape And Company Profiles

• 30.1. Varenicline Market Competitive Landscape
• 30.2. Varenicline Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Biocon Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Oyster Point Pharma Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Viatris Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Teva Pharmaceutical Industries Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Varenicline Market Other Major And Innovative Companies

• 31.1. Sandoz International GmbH
• 31.2. Nanjing Clasien Pharmaceutical & Chemical Co. Ltd.
• 31.3. Hetero Drugs Limited
• 31.4. Sun Pharmaceutical Industries Ltd
• 31.5. Aurobindo Pharma Limited
• 31.6. Dr. Reddy's Laboratories Ltd.
• 31.7. Cipla Limited
• 31.8. Apotex Inc
• 31.9. Amneal Pharmaceuticals LLC
• 31.10. Lupin Limited
• 31.11. Alkem Laboratories Ltd
• 31.12. Glenmark Pharmaceuticals Limited
• 31.13. Jubilant Life Sciences Limited
• 31.14. Alembic Pharmaceuticals Limited
• 31.15. Torrent Pharmaceuticals Ltd.

32. Global Varenicline Market Competitive Benchmarking

33. Global Varenicline Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Varenicline Market

35. Varenicline Market Future Outlook and Potential Analysis

• 35.1 Varenicline Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Varenicline Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Varenicline Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer